Meredith A. Mintzer

Triazine Dendrimers as Nonviral Vectors for in Vitro and in Vivo RNAi: The Effects of Peripheral Groups and Core Structure on Biological Activity

Olivia M. Merkel, Meredith A. Mintzer, Damiano Librizzi et al. · Molecular Pharmaceutics · 2010 · 98 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +15

Triazine Dendrimers as Nonviral Gene Delivery Systems: Effects of Molecular Structure on Biological Activity

Olivia M. Merkel, Meredith A. Mintzer, Johannes Sitterberg et al. · Bioconjugate Chemistry · 2009 · 82 citations

Pharmacy, Biotechnology, Medicinal Chemistry +17

Computational Insights into the Interactions between DNA and siRNA with “Rigid” and “Flexible” Triazine Dendrimers

Giovanni M. Pavan, Meredith A. Mintzer, Eric E. Simanek et al. · Biomacromolecules · 2010 · 78 citations

Natural Sciences, Biophysics, Molecular Biology +16

The 8 year thicket of triazine dendrimers: strategies, targets and applications

Eric E. Simanek, H.E. Abdou, Sanjiv Lalwani et al. · Proceedings of the Royal Society A Mathematical Physical and Engineering Sciences · 2009 · 74 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +10

Molecular modeling and in vivo imaging can identify successful flexible triazine dendrimer-based siRNA delivery systems

Olivia M. Merkel, Mengyao Zheng, Meredith A. Mintzer et al. · Journal of Controlled Release · 2011 · 50 citations

Pharmacy, Molecular Pharmaceutics, Pharmaceutics +14